Inozyme Pharma has filed a notice of a Private Investment in Public Equity (PIPE) offering of securities to raise $64,500,000.00 in Post-IPO Equity.
According to filings with the U.S. Securities and Exchange Commission, Inozyme Pharma is raising $64,500,000.00 in new funding. About Inozyme Pharma: Inozyme Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel therapeutics for the…
